COSCIENS Biopharma Inc. Current Accrued Expenses And Other Current Liabilities
COSCIENS Biopharma Inc. (CSCIF) had Current Accrued Expenses And Other Current Liabilities of $1.88 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities · last filed 2026-03-25
- 2025-12-31: Current Accrued Expenses And Other Current Liabilities $1.88M.
- 2025-09-30: Current Accrued Expenses And Other Current Liabilities $1.95M.
- 2025-06-30: Current Accrued Expenses And Other Current Liabilities $3.06M.
- 2025-03-31: Current Accrued Expenses And Other Current Liabilities $4.71M.
| Period end | Current Accrued Expenses And Other Current Liabilities | Current Accrued Expenses And Other Current Liabilities as first filed |
|---|---|---|
| 2025-12-31 | $1.88M 20-F · filed 2026-03-25 | |
| 2025-09-30 | $1.95M 6-K · filed 2025-11-12 | |
| 2025-06-30 | $3.06M 6-K · filed 2025-08-14 | |
| 2025-03-31 | $4.71M 6-K · filed 2025-05-13 | |
| 2024-12-31 | $4.73M 20-F · filed 2026-03-25 | |
| 2024-09-30 | $4.82M 6-K · filed 2024-11-12 | |
| 2024-06-30 | $5.84M 6-K · filed 2024-08-13 | |
| 2024-03-31 | $4.32M 6-K · filed 2024-05-16 | |
| 2023-12-31 | $1.01M 20-F · filed 2025-04-09 | $3.62M 20-F · filed 2024-03-27 |
| 2023-09-30 | $3.30M 6-K · filed 2023-11-09 | |
| 2023-06-30 | $3.57M 6-K · filed 2023-08-09 | |
| 2023-03-31 | $3.62M 6-K · filed 2024-05-16 | $4.13M 6-K · filed 2023-05-09 |
| 2022-12-31 | $3.83M 20-F/A · filed 2024-07-17 | |
| 2021-12-31 | $2.67M 20-F/A · filed 2024-02-15 |